Warfarin Treatment in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease Sins of Omission or Commission?

被引：12
|
作者：
Winkelmayer, Wolfgang C. [1 ,2 ]
Turakhia, Mintu P. [3 ,4 ]
机构：
[1] Stanford Univ, Sch Med, Div Nephrol, Dept Med, Palo Alto, CA 94304 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA
[3] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA
[4] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2014年 / 311卷 / 09期
关键词：
ORAL ANTICOAGULATION; RISK-FACTORS; STROKE; PREVENTION; HEMORRHAGE; TRIAL;
D O I：
10.1001/jama.2014.1781
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：913 / 915
页数：3
相关论文
共 50 条
  • [41] The impact of anticoagulation therapy on kidney function in patients with atrial fibrillation and chronic kidney disease
    Simic, Jelena
    Mihajlovic, Miroslav
    Zec, Nevena
    Kovacevic, Vladan
    Marinkovic, Milan
    Mujovic, Nebojsa
    Potpara, Tatjana
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2023, 21 (12) : 937 - 945
  • [42] Warfarin Initiation, Atrial Fibrillation, and Kidney Function: Comparative Effectiveness and Safety of Warfarin in Older Adults With Newly Diagnosed Atrial Fibrillation
    Jun, Min
    James, Matthew T.
    Ma, Zhihai
    Zhang, Jianguo
    ToneIli, Marcello
    McAlister, Finlay A.
    Manns, Braden J.
    Ravani, Pietro
    Quinn, Robert R.
    Wiebe, Natasha
    Perkovic, Vlado
    Wilton, Stephen B.
    Winkelmayer, Wolfgang C.
    Hemmelgarn, Brenda R.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (06) : 734 - 743
  • [43] Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
    Hylek, Elaine M.
    Held, Claes
    Alexander, John H.
    Lopes, Renato D.
    De Caterina, Raffaele
    Wojdyla, Daniel M.
    Huber, Kurt
    Jansky, Petr
    Steg, Philippe Gabriel
    Hanna, Michael
    Thomas, Laine
    Wallentin, Lars
    Granger, Christopher B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (20) : 2141 - 2147
  • [44] Are the novel anticoagulants better than warfarin for patients with atrial fibrillation?
    Hanley, Colleen M.
    Kowey, Peter R.
    JOURNAL OF THORACIC DISEASE, 2015, 7 (02) : 165 - 171
  • [45] Edoxaban versus Warfarin in Patients with Atrial Fibrillation
    Giugliano, Robert P.
    Ruff, Christian T.
    Braunwald, Eugene
    Murphy, Sabina A.
    Wiviott, Stephen D.
    Halperin, Jonathan L.
    Waldo, Albert L.
    Ezekowitz, Michael D.
    Weitz, Jeffrey I.
    Spinar, Jindrich
    Ruzyllo, Witold
    Ruda, Mikhail
    Koretsune, Yukihiro
    Betcher, Joshua
    Shi, Minggao
    Grip, Laura T.
    Patel, Shirali P.
    Patel, Indravadan
    Hanyok, James J.
    Mercuri, Michele
    Vogelmann, O.
    Gonzalez, C.
    Ahuad Guerrero, R.
    Rodriguez, M.
    Albisu, J.
    Rosales, E.
    Allall, O.
    Reguero, M.
    Alvarez, C.
    Garcia, M.
    Ameriso, S.
    Ameriso, P.
    Amuchastegui, M.
    Caceres, M.
    Beloscar, J.
    Petrucci, J.
    Berli, M.
    Budassi, N.
    Valle, M.
    Bustamante Labarta, G.
    Saravia, M.
    Caccavo, A.
    Fracaro, V.
    Cartasegna, L.
    Novas, V.
    Caruso, O.
    Saa Zarandon, R.
    Colombo, H.
    Morandini, M.
    Cuello, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (22) : 2093 - 2104
  • [46] Apixaban versus Warfarin in Patients with Atrial Fibrillation
    Granger, Christopher B.
    Alexander, John H.
    McMurray, John J. V.
    Lopes, Renato D.
    Hylek, Elaine M.
    Hanna, Michael
    Al-Khalidi, Hussein R.
    Ansell, Jack
    Atar, Dan
    Avezum, Alvaro
    Cecilia Bahit, M.
    Diaz, Rafael
    Easton, J. Donald
    Ezekowitz, Justin A.
    Flaker, Greg
    Garcia, David
    Geraldes, Margarida
    Gersh, Bernard J.
    Golitsyn, Sergey
    Goto, Shinya
    Hermosillo, Antonio G.
    Hohnloser, Stefan H.
    Horowitz, John
    Mohan, Puneet
    Jansky, Petr
    Lewis, Basil S.
    Luis Lopez-Sendon, Jose
    Pais, Prem
    Parkhomenko, Alexander
    Verheugt, Freek W. A.
    Zhu, Jun
    Wallentin, Lars
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (11) : 981 - 992
  • [47] Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry
    Park, Hanjin
    Yu, Hee Tae
    Kim, Tae-Hoon
    Park, Junbeom
    Park, Jin-Kyu
    Kang, Ki-Woon
    Shim, Jaemin
    Kim, Jin-Bae
    Kim, Jun
    Choi, Eue-Keun
    Park, Hyung Wook
    Lee, Young Soo
    Joung, Boyoung
    YONSEI MEDICAL JOURNAL, 2023, 64 (01) : 18 - 24
  • [48] Anticoagulation in patients with non-valvular atrial fibrillation (nvAF) and chronic kidney disease (CKD)
    Zeymer, Uwe
    Bonnemeier, Hendrik
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (23) : 1642 - 1649
  • [49] Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
    Reddy, Vivek Y.
    Akehurst, Ronald L.
    Armstrong, Shannon O.
    Amorosi, Stacey L.
    Brereton, Nic
    Hertz, Deanna S.
    Holmes, David R., Jr.
    EUROPACE, 2016, 18 (07): : 979 - 986
  • [50] Stroke and Bleeding in Atrial Fibrillation with Chronic Kidney Disease
    Olesen, Jonas Bjerring
    Lip, Gregory Y. H.
    Kamper, Anne-Lise
    Hommel, Kristine
    Kober, Lars
    Lane, Deirdre A.
    Lindhardsen, Jesper
    Gislason, Gunnar Hilmar
    Torp-Pedersen, Christian
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07) : 625 - 635
12345